BTS
IBB icon

BB&T Securities’s iShares Biotechnology ETF IBB Stock Holding History

BB&T Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.04M Sell
10,472
-8,235
-44% -$862K 0.01% 780
2019
Q2 		$2.04M Sell
18,707
-965
-5% -$103K 0.02% 579
2019
Q1 		$2.2M Sell
19,672
-4,707
-19% -$516K 0.02% 549
2018
Q4 		$2.35M Sell
24,379
-2,325
-9% -$247K 0.03% 508
2018
Q3 		$3.26M Buy
26,704
+232
+0.9% +$27.3K 0.03% 486
2018
Q2 		$2.91M Sell
26,472
-726
-3% -$77.6K 0.03% 499
2018
Q1 		$2.9M Sell
27,198
-102,002
-79% -$11.3M 0.03% 489
2017
Q4 		$13.8M Sell
129,200
-1,420
-1% -$152K 0.18% 151
2017
Q3 		$14.5M Buy
130,620
+1,257
+1% +$134K 0.2% 137
2017
Q2 		$13.4M Buy
129,363
+13,860
+12% +$1.37M 0.19% 140
2017
Q1 		$11.3M Sell
115,503
-11,043
-9% -$1.06M 0.15% 170
2016
Q4 		$12.1M Buy
126,546
+8,895
+8% +$810K 0.18% 142
2016
Q3 		$11.4M Buy
117,651
+27,888
+31% +$2.65M 0.17% 150
2016
Q2 		$7.7M Sell
89,763
-45,036
-33% -$4.04M 0.12% 193
2016
Q1 		$11.7M Sell
134,799
-68,109
-34% -$6.09M 0.19% 121
2015
Q4 		$22.9M Buy
202,908
+6,669
+3% +$724K 0.48% 63
2015
Q3 		$19.8M Buy
196,239
+17,433
+10% +$2.09M 0.44% 68
2015
Q2 		$22M Sell
178,806
-5,430
-3% -$650K 0.47% 61
2015
Q1 		$21.1M Buy
184,236
+34,038
+23% +$3.75M 0.46% 60
2014
Q4 		$15.2M Buy
150,198
+9,804
+7% +$953K 0.34% 75
2014
Q3 		$12.8M Buy
140,394
+1,980
+1% +$174K 0.3% 81
2014
Q2 		$11.9M Sell
138,414
-4,827
-3% -$380K 0.28% 77
2014
Q1 		$11.3M Sell
143,241
-40,524
-22% -$3.38M 0.29% 78
2013
Q4 		$13.9M Buy
183,765
+27,726
+18% +$1.97M 0.38% 68
2013
Q3 		$10.9M Buy
156,039
+90,057
+136% +$5.9M 0.34% 72
2013
Q2 		$3.82M Buy
+65,982
New +$3.81M 0.13% 135

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BB&T Securities's IBB Position: Q3 2019 in Review

BB&T Securities reduced its iShares Biotechnology ETF (IBB) stake by 44% in Q3 2019, selling an estimated $862K and leaving 10,472 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #780.

BB&T Securities first reported a position in IBB in Q2 2013 and has held it in 26 quarters since. The position peaked at $22.9M in Q4 2015. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • BB&T Securities held 10,472 shares of iShares Biotechnology ETF worth $1.04M as of Q3 2019.
  • BB&T Securities sold 8,235 iShares Biotechnology ETF shares in Q3 2019, an estimated $862K.
  • iShares Biotechnology ETF made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #780 holding.
  • BB&T Securities first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's iShares Biotechnology ETF position peaked at $22.9M in Q4 2015.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.